" Wearable Injectors Market by Product Type(On-Body and Off-Body), Therapy (Immuno-oncology, Diabetes, Cardiovascular diseases), Technology(Spring-based, Motor Driven, Rotary Pump, Expanding Battery), Care Setting (Hospitals) - Global Forecast to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 11.5 billion by 2026 from USD 7.2 billion in 2021, at a CAGR of 9.9% during the forecast period.
Browse in-depth TOC on "Wearable Injectors Market"
114 – Tables
51 – Figures
196 – Pages
Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=100771004
The Growth in this market is mainly driven by factors such as the shift of
healthcare delivery toward homecare due to COVID-19, advantages of wearable
injectors in the administration of various drugs, the rising prevalence of
chronic diseases (such as cancer, diabetes, and CVD), favorable reimbursement
scenario in major markets, and technological advancements in injector devices.
However, the preference for alternative drug delivery modes, high costs, and a
poor reimbursement structure in developing countries are expected to limit the
adoption of wearable injectors to a certain extent.
By Type, the on-body
injectors segment is expected to account for the largest share of the wearable
injectors market
By type, the global market is segmented into on-body injectors
and off-body injectors. The on-body injectors segment accounted for the largest
share in the forecast year. The large share of this segment can be attributed
to the patients ease to deliver a precise amount of drug to the body over a
controlled period of time.
On the basis of
technology, spring based segment is expected to account for the largest share
of the market
Based on technology, the wearable injectors market is segmented
into spring-based, motor-driven, rotary pump, expanding battery, and other
technologies. The spring-based technology segment accounted for the largest
share in the forecast period. The large share of this segment can be attributed
to the rising demand for adhesive patches, as these devices are user-friendly
and enable patients to accurately deliver the required drug subcutaneously.
Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=100771004
On the basis of
therapy, diabetes segment is expected to account for the largest share of the
market
Based on therapy, the wearable injectors market is segmented
into immuno-oncology, diabetes, cardiovascular diseases, and other therapies
(such as Parkinson's disease, thalassemia, and primary immunodeficiency
disorders). The diabetes segment accounted for the largest share in the
forecast period. The large share of this segment can be attributed to The high
burden of diabetes across the globe, coupled with the growing availability of
wearable injectors for the treatment of these diseases, is driving the growth
of this market segment.
On the basis of end
user, hospitals and clinics segment holds the highest market share in the
wearable injectors market
Based on end user, the market is segmented into hospitals and
clinics and home healthcare settings. The hospitals and clinics segment
accounted for a larger market share during the forecast period. The large share
of this segment can primarily be attributed to the rising preference for the
self-administration of medication and the increasing need to curb healthcare
costs. In addition, the growing demand for technologically developed drug
delivery approaches, which lower the hospitalization rate and require minimal
expertise, is expected to boost the growth of the home healthcare settings
segment.
Speak to Analyst: -https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=100771004
North America to dominate the
wearable injectors market during the forecast period
The wearable injector market in North America accounted for
the largest market during the forecast period. The large share of North America in
this market is to the rising prevalence of chronic and lifestyle-related
diseases and the presence of advanced healthcare infrastructure in the region.
However, the Europe market
is estimated to grow at the highest CAGR during the forecast period owing to factors
such as the Increasing prevalence of chronic diseases, Government support for
drug development in Germany,
Rising focus on biosimilar innovation in the UK, Favorable reimbursement
scenario for various treatment options in France.
Prominent players in the wearable injectors market include
Becton, Dickinson and Company(US), Ypsomed(Switzerland), Amgen(US), Subcuject(Denmark),
Enable Injections, Inc(US), Medtronic Plc(Ireland), Insulet Corporation(US),
United Therapeutics Corp (Us), CeQur SA(Switzerland), Sensile Medical(Switzerland).
About
MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000
high growth niche opportunities/threats which will impact 70% to 80% of
worldwide companies' revenues. Currently servicing 7500 customers worldwide
including 80% of global Fortune 1000 companies as clients. Almost 75,000 top
officers across eight industries worldwide approach MarketsandMarkets™ for
their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are
tracking global high growth markets following the "Growth Engagement Model
– GEM". The GEM aims at proactive collaboration with the clients to
identify new opportunities, identify most important customers, write
"Attack, avoid and defend" strategies, identify sources of
incremental revenues for both the company and its competitors.
MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies, innovators, strategic players)
annually in high growth emerging segments. MarketsandMarkets™ is determined to
benefit more than 10,000 companies this year for their revenue planning and
help them take their innovations/disruptions early to the market by providing
them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market
research platform, "Knowledge Store" connects over 200,000 markets
and entire value chains for deeper understanding of the unmet insights along
with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish
Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA:
+1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/wearable-injector-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/wearable-injector.asp
No comments:
Post a Comment